Pyrroloquinoline Quinone Alleviates Jejunal Mucosal Barrier Function Damage and Regulates Colonic Microbiota in Piglets Challenged With Enterotoxigenic Escherichia coli

Caiyun Huang,Dongxu Ming,Wenhui Wang,Zijie Wang,Yongfei Hu,Xi Ma,Fenglai Wang
DOI: https://doi.org/10.3389/fmicb.2020.01754
IF: 5.2
2020-07-24
Frontiers in Microbiology
Abstract:This study aimed to evaluate the effect of dietary supplementation with pyrroloquinoline quinone (PQQ) on gut inflammation and microbiota dysbiosis induced by enterotoxigenic <i>Escherichia coli</i> (ETEC). Twenty Duroc × Landrace × Yorkshire crossbred barrows were assigned to four groups: two <i>E. coli</i> K88 challenge groups and two non-challenge groups, each provided a basal diet supplemented with 0 or 3 mg/kg PQQ. On day 14, piglets were challenged with 10 mL 1 × 10<sup>9</sup> CFU/mL of <i>E. coli</i> K88 or PBS for 48 h. The villus height (VH) and villus height/crypt depth (VCR) ratio of the <i>E. coli</i> K88-challenged group supplemented with PQQ was significantly reduced than in the non-supplemented challenge group (<i>P</i> &lt; 0.05), while levels of jejunal zonula occludens-3 (ZO-3), diamine oxidase, secretory immunoglobulin A (SIgA), interleukin-10 (IL-10), and IL-22 proteins were higher (<i>P</i> &lt; 0.05), as were the activities of glutathione peroxidase, total superoxide dismutase, and total antioxidant capability (<i>P</i> &lt; 0.05). Moreover, PQQ supplementation alleviated an increase in levels of mucosal inflammatory cytokines and reduced the activity of nuclear factor-kappa B (NF-κB) pathway by <i>E. coli</i> K88 (<i>P</i> &lt; 0.05). Gene sequencing of 16S rRNA showed dietary supplementation with PQQ in <i>E. coli</i> K88-challenged piglets attenuated a decrease in <i>Lactobacillus</i> count and butyrate, isobutyrate level, and an increase in <i>Ruminococcus</i> and <i>Intestinibacter</i> counts, all of which were observed in non-supplemented, challenge-group piglets. These results suggest that dietary supplementation with PQQ can effectively alleviate jejunal mucosal inflammatory injury by inhibiting NF-κB pathways and regulating the imbalance of colonic microbiota in piglets challenged with <i>E. coli</i> K88.
microbiology
What problem does this paper attempt to address?